Placeholder Banner

Life Sciences Community Joins Rep. Charlie Dent to Discuss State of the Industry and Positive Impact on Pennsylvania

August 18, 2016

WHAT: Roundtable discussion about the life sciences landscape, including the industry’s economic impact on Pennsylvania, the value of innovation, bioscience education opportunities, NIH funding and research best practices. Rep. Charlie Dent and Hon. Jim Greenwood to deliver remarks

WHO:
• Rep. Charlie Dent (R-PA-15)
• Hon. Jim Greenwood, President & CEO, BIO; former PA Congressman
• Mr. Craig Tucker, Vice President, PA BIO • Dr. Keri Donaldson, Founder, Prescient Medicine
• Dr. Ralf Brandt, CEO & Managing Director, vivoPharm
• Dr. Kent Vrana, Professor & Chair, Penn State Dept. of Pharmacology
• Dr. Mel Billingsley, President & CEO, Life Sciences Greenhouse of Central PA
• Ms. Caitlin Orr, Project Coordinator, Hershey Center for Applied Research
• Mr. Nick Magallanes, Director Federal Government Relations, BIO

WHEN: Tuesday, August 23, 2016, 1:30 to 2:30 p.m. (Eastern Time Zone)

WHERE:
Hershey Center for Applied Research
Room 1103
1214 Research Boulevard
Hummelstown, PA 17036  


https://www.bio.org/sites/default/files/SP_Pennsylvania_0.pdf

 

Discover More
BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth   Washington, DC, May 28, 2025 – The Biotechnology Innovation…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…